119 related articles for article (PubMed ID: 18950634)
21. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
22. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patients.
Velthuis JH; Hesselink DA; Hendrikx TK; van der Mast BJ; Klepper M; de Greef GE; Baan CC; Weimar W
Transpl Immunol; 2007 Nov; 18(2):159-65. PubMed ID: 18005862
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T-cells in periapical lesions.
Colić M; Gazivoda D; Vucević D; Majstorović I; Vasilijić S; Rudolf R; Brkić Z; Milosavljević P
J Dent Res; 2009 Nov; 88(11):997-1002. PubMed ID: 19828886
[TBL] [Abstract][Full Text] [Related]
26. CD4+CD25high regulatory cells in peripheral blood of cancer patients.
Liu L; Wu G; Yao JX; Ding Q; Huang SA
Neuro Endocrinol Lett; 2008 Apr; 29(2):240-5. PubMed ID: 18404145
[TBL] [Abstract][Full Text] [Related]
27. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity?
Genre J; Errante PR; Kokron CM; Toledo-Barros M; Câmara NO; Rizzo LV
Clin Immunol; 2009 Aug; 132(2):215-21. PubMed ID: 19394278
[TBL] [Abstract][Full Text] [Related]
28. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
[TBL] [Abstract][Full Text] [Related]
29. Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion.
Szegedi A; Baráth S; Nagy G; Szodoray P; Gál M; Sipka S; Bagdi E; Banham AH; Krenács L
Br J Dermatol; 2009 May; 160(5):984-93. PubMed ID: 19222459
[TBL] [Abstract][Full Text] [Related]
30. Isolation of CD4+CD25+ regulatory T cells for clinical trials.
Hoffmann P; Boeld TJ; Eder R; Albrecht J; Doser K; Piseshka B; Dada A; Niemand C; Assenmacher M; Orsó E; Andreesen R; Holler E; Edinger M
Biol Blood Marrow Transplant; 2006 Mar; 12(3):267-74. PubMed ID: 16503495
[TBL] [Abstract][Full Text] [Related]
31. Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Assunta B; Plantone D; Cammarota G; Tonali PA; Batocchi AP
Hum Immunol; 2009 Jun; 70(6):430-5. PubMed ID: 19364517
[TBL] [Abstract][Full Text] [Related]
32. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
33. CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2.
Pedersen AE; Lauritsen JP
Scand J Immunol; 2009 Jul; 70(1):40-3. PubMed ID: 19522766
[TBL] [Abstract][Full Text] [Related]
34. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage.
Jin LP; Chen QY; Zhang T; Guo PF; Li DJ
Clin Immunol; 2009 Dec; 133(3):402-10. PubMed ID: 19766059
[TBL] [Abstract][Full Text] [Related]
35. CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.
Feyler S; von Lilienfeld-Toal M; Jarmin S; Marles L; Rawstron A; Ashcroft AJ; Owen RG; Selby PJ; Cook G
Br J Haematol; 2009 Mar; 144(5):686-95. PubMed ID: 19133978
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive.
Noël G; Brinster C; Semana G; Bruniquel D
Int Immunol; 2009 Sep; 21(9):1025-36. PubMed ID: 19625380
[TBL] [Abstract][Full Text] [Related]
37. Distribution of CD4+ CD25 high FoxP3+ regulatory T-cells in umbilical cord blood.
Kim H; Moon HW; Hur M; Park CM; Yun YM; Hwang HS; Kwon HS; Sohn IS
J Matern Fetal Neonatal Med; 2012 Oct; 25(10):2058-61. PubMed ID: 22348656
[TBL] [Abstract][Full Text] [Related]
38. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells.
Grindebacke H; Stenstad H; Quiding-Järbrink M; Waldenström J; Adlerberth I; Wold AE; Rudin A
J Immunol; 2009 Oct; 183(7):4360-70. PubMed ID: 19734224
[TBL] [Abstract][Full Text] [Related]
39. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.
Dijke IE; Korevaar SS; Caliskan K; Balk AH; Maat AP; Weimar W; Baan CC
Transplantation; 2009 Apr; 87(8):1191-200. PubMed ID: 19384166
[TBL] [Abstract][Full Text] [Related]
40. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
